Cite
HARVARD Citation
Ha, C. et al. (2016). Prospective, randomized, double-blinded, double-dummy and multicenter phase IV clinical study comparing the efficacy and safety of PG201 (Layla) and SKI306X in patients with osteoarthritis. Journal of ethnopharmacology. pp. 1-7. [Online].